Smith, Moore & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
2,075
-55
| -3% | -$6.1K | 0.02% | 456 |
|
|
2025
Q1 | $239K | Sell |
2,130
-1,000
| -32% | -$112K | 0.02% | 425 |
|
|
2024
Q4 | $289K | Buy |
3,130
+16
| +0.5% | +$1.48K | 0.03% | 377 |
|
|
2024
Q3 | $261K | Buy |
3,114
+21
| +0.7% | +$1.76K | 0.02% | 385 |
|
|
2024
Q2 | $212K | Sell |
3,093
-28
| -0.9% | -$1.92K | 0.02% | 414 |
|
|
2024
Q1 | $229K | Buy |
3,121
+215
| +7% | +$15.8K | 0.02% | 385 |
|
|
2023
Q4 | $235K | Sell |
2,906
-14
| -0.5% | -$1.13K | 0.03% | 368 |
|
|
2023
Q3 | $219K | Buy |
2,920
+1
| +0% | +$75 | 0.03% | 353 |
|
|
2023
Q2 | $225K | Buy |
2,919
+151
| +5% | +$11.6K | 0.03% | 360 |
|
|
2023
Q1 | $230K | Hold |
2,768
| – | – | 0.03% | 345 |
|
|
2022
Q4 | $238K | Buy |
+2,768
| New | +$238K | 0.03% | 331 |
|
|
2017
Q4 | – | Sell |
-3,275
| Closed | -$265K | – | 307 |
|
|
2017
Q3 | $265K | Buy |
3,275
+129
| +4% | +$10.4K | 0.08% | 239 |
|
|
2017
Q2 | $223K | Buy |
3,146
+1
| +0% | +$71 | 0.07% | 217 |
|
|
2017
Q1 | $214K | Buy |
3,145
+294
| +10% | +$20K | 0.08% | 217 |
|
|
2016
Q4 | $204K | Sell |
2,851
-34
| -1% | -$2.43K | 0.08% | 214 |
|
|
2016
Q3 | $228K | Sell |
2,885
-697
| -19% | -$55.1K | 0.09% | 190 |
|
|
2016
Q2 | $299K | Sell |
3,582
-54
| -1% | -$4.51K | 0.12% | 157 |
|
|
2016
Q1 | $334K | Buy |
3,636
+1,367
| +60% | +$126K | 0.14% | 137 |
|
|
2015
Q4 | $230K | Buy |
+2,269
| New | +$230K | 0.11% | 155 |
|